Advancing BRS through innovative biomaterials

Sponsored by REVA MEDICAL

Chairperson: A. Abizaid
Co-Chairperson: N. Frey

Learning Objectives

  • To gain insight into Reva's novel biomaterials
  • To get a better understanding of the implant and imaging advantages of the Fantom scaffold
  • To see current clinical data from the FANTOM BRS clinical trial series

Presentations available when logged in:

  • Session objectives
  • Advantages of desaminotyrosine polycarbonate polymers
  • Case reviews: results from selected Fantom clinical cases
  • FANTOM II trial: clinical results from the Fantom sirolimus-eluting BRS